Justin Mark, M.D.

🌟1/ Excited to share our work: “Personalizing Temperature Targets After Cardiac Arrest: Our Neurologically Driven Approach” now officially featured in JACC: Advances Special Edition Care of the Critically Ill in the Cardiac ICU 🔗jacc.org/doi/10.1016/j.… 🙏With incredible support from my amazing mentors and coauthors: @carlosalviar @jllbmd @waseemwahood @russcolombomd @DanckersMD @DrDamluji @JasonKatzMD and @JACCJournals @CandiceSilvers1 👇 Summary below:

Smith: “NSTEMI” is worthless diagnosis. 30-40% of NSTEMI are Occlusion MI, and they have far worse prognosis than NSTEMI with open arteries, in spite of being younger and healthier at baseline. NEVER diagnose someone with NSTEMI. It is a worthless diagnosis.  Very true✅

@PopesFFH Godwin or Jakobi Meyers PPR

@AustinAbbott Godwin or Jakobi Meyers PPR?

WEEK 13 START SIT QUESTIONS GO

#AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, systemic embolism or new embolic stroke vs ASA among high risk patients for stroke post ablation 1-year prior @NEJM nejm.org/doi/full/10.10… 2) #ADAPT_AF NOAC monotherapy was noninferior to combination for net adverse clinical events in AF patients who had undergone DES 1-year prior @NEJM nejm.org/doi/full/10.10… 3) #OPTIMA_AF 1-mo was as effective as 12-mo dual antithrombotic therapy w DOAC & P2Y12 inhibitor, followed by the oral anticoag alone for preventing stroke, MI & death & fewer bleeding than long dual Rx 4) #CLOSURE_AF Physician-directed standard medical Rx (anticoag) was better than LAAC in patients with AFib & at high risk of stroke & major bleeding

Outstanding primer on the residual role for targeted temperature management in the post arrest setting with @carlosalviar and @AndreaElliottUM - happening now in the simulation size #AHA2025

🚨Proud to present our latest article in #JACCCaseReports to be presented at #AHA2025 this weekend by co-first author and superstar @RubenKTapia as a simultaneous publication: ❤️‍🔥Smoldering Myocarditis Unmasked by Pembrolizumab-Induced Myositis: Delayed-Onset Double M Syndrome 💊 ICI-related double M syndromes are rare, high-risk, and often acute, but this delayed, smoldering case shows why subacute forms matter. Early recognition + multimodal imaging, even in delayed or silent cases, can be lifesaving. 🙏🏼Thanks to @JACCJournals for their support. 👇👇👇 jacc.org/doi/10.1016/j.…

Don’t miss this! Everything you ever wanted to know about RV Failure just in time for your next shift in the #CICU! And who better to learn from than @RyanTedfordMD !

Come join us for the @FloridaACC Journal Club! 🔔 🗓 Oct 9 | 🕕 6–7 PM ET Discussing 3 landmark ESC ASM 2025 trials with: 👨‍🏫 Moderator: Robby Wu, DO, FACC (USF) 🫀 DIGIT-HF: Leonardo A. Almaguer Gongora, MD – HCA Aventura 💓 MAPLE-HCM: Nguyen Nguyen, MD – NCH Rooney Heart Institute ❤️ REBOOT-CNIC: Kinley Buckley, DO – USF Register 👉 accfl.org/event-6367985 #CardioTwitter #ACCFIT #FIT #MedEd @ACCinTouch @rzw113 @XavierPrida @dkenigsberg @CarlosVergaraMD @JustinMarkMD @SephienMD @RheaSancassani @russcolombomd

🙏 12/ Grateful to my coauthors & mentors for pushing this conversation forward. Honored to contribute to advancing care for patients after cardiac arrest.

💡 11/ Take-home: Post–cardiac arrest care may move beyond “one-size-fits-all.” A neurologically centered, tailored TTM approach (TTM-HT vs TTM-NT) may optimize outcomes.

🌟1/ Excited to share our work: “Personalizing Temperature Targets After Cardiac Arrest: Our Neurologically Driven Approach” now officially featured in JACC: Advances Special Edition Care of the Critically Ill in the Cardiac ICU 🔗jacc.org/doi/10.1016/j.… 🙏With incredible support from my amazing mentors and coauthors: @carlosalviar @jllbmd @waseemwahood @russcolombomd @DanckersMD @DrDamluji @JasonKatzMD and @JACCJournals @CandiceSilvers1 👇 Summary below: